Proteomic Biomarker Shop CS-Keys Closes Seed Round of VC Financing | GenomeWeb
NEW YORK (GenomeWeb News) - Proteomics company CS-Keys said yesterday that it has received a "significant" but undisclosed seed investment from Midwest VC firm Triathlon Medical Ventures.
CS-Keys, based in Indianapolis, will use the investment to continue researching and developing its cancer-specific biomarkers and supporting its marketing and regulatory strategies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.